HomeWomen's HealthStatements & GuidelinesNew & Revised Statements and Guidelines

College Statements Update

From 2011
The following statements were re-endorsed by RANZCOG Council and Board in November 2011

 
  • Policy Statement on Shared Maternity Care Obstetric Patients in Australia (WPI 9)
  • Guidelines for locum positions in specialist obstetric and gynaecological practice in Australia and New Zealand (WPI 12) 
  • Home Births (C-Obs 2)
  • Management of the Menopause (C-Gyn 9)
  • Management of the Menopause after Breast Cancer (C-Gyn 15)
  • Diagnosis of Gestational Diabetes Mellitus (C-Obs 7)
  • Placenta Accreta (C-Obs 20)
  • Use of Cervical Fetal Fibronectin and Phosphorylated Insulin-Like Growth Factor Binding Protein 1 as Screening Tests for Preterm Birth ( C-Obs 26)
  • Women and Smoking (C-Gen 5)
  • Guidelines for the use of Rh (D) Immunoglobulin (Anti-D) in obstetrics in Australia (C-Obs 6)
  • Re-entry guidelines following a prolonged period of absence from practice and retraining programs for Fellows (WPI 13)

New College Statements
The following new statements were endorsed by RANZCOG Council and Board in March 2012 and November 2011:

 
  • The Personally Controlled Electronic Health Record (WPI 22)
  • Perinatal Anxiety and Depression (C-Gen 18)
  • Cultural Competency (WPI 20)
  • Antibiotic Prophylaxis for Obstetric and Gynaecological Surgery (C-Gen 17)
  • Influenza Vaccination for Pregnant Women (C-Obs 45)
  • Guidelines for Scanning of Live Subjects for Teaching Purposes (WPI 21)

Revised College Statements
The following statements were re-endorsed by RANZCOG Council and Board in March 2012 with significant amendments:

 
  • RANZCOG Guideline: Suitability Criteria for Models of Care and Indications for Referral within & between Models of Care (C-Obs 30)
  • Investigation of Intermenstrual and Post-Coital Bleeding (C-Gyn 6)
  • Tamoxifen and the Endometrium (C-Gyn 12)
  • Termination of Pregnancy (C-Gyn 17)
  • Guidelines for the appointment of O&Gs to Specialist Positions in Aust & NZ (WPI 17)

The following statements were re-endorsed by RANZCOG Council and Board in March 2012 with minor or no amendments:

 
  • Timing of Elective Caesarean Section at Term (C-Obs 23)
  • Use of Prostaglandins for Cervical Ripening prior to the Induction of Labour (C-Obs 22)
  • RANZCOG Standards in Maternity Care in Australia and New Zealand (C-Obs 41)
  • RANZCOG/ ANZCA/ RACGP/ ACRRM Position Statement on the Provision of Obstetric Anaesthesia Services (WPI 14)
  • Umbilical Cord Blood Banking (C-Obs 18)
  • Position Statement on the Appropriate Use of Diagnostic Ultrasound (C-Gen 10)
  • Use of the Veres needle to obtain pneumoperitoneum prior to laparoscopy (C-Gyn 7)

New College Statements under development

 
  • Routine testing of serum TSH level in pregnant women
  • Vasa Previa
  • Illicit Drugs in Pregnancy
  • Oral Contraceptive Pill 


Louise Farrell
Chair
Women’s Health Committee
March 2012

 
Go to top

Copyright © 2011 Royal Australian and New Zealand College of Obstetricians and Gynaecologists. ABN: 34 100 268 969